(Q35207091)

7 August 2017

1 reference

title

Syngeneic graft-versus-host disease: a report of two cases and literature review (English)

1 reference

7 August 2017

Latif T

1

1 reference

7 August 2017

Pohlman B

2

1 reference

7 August 2017

Kalaycio M

3

1 reference

7 August 2017

Sobecks R

4

1 reference

7 August 2017

Hsi ED

5

1 reference

7 August 2017

Andresen S

6

1 reference

7 August 2017

Bolwell BJ

7

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

Bone Marrow Transplantation

7 August 2017

published in

1 reference

7 August 2017

volume

32

1 reference

7 August 2017

issue

5

1 reference

7 August 2017

page(s)

535-539

1 reference

Development of graft-vs.-host disease-like syndrome in cyclosporine-treated rats after syngeneic bone marrow transplantation. I. Development of cytotoxic T lymphocytes with apparent polyclonal anti-Ia specificity, including autoreactivity

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704171

Acute graft-versus-host disease in recipients of bone-marrow transplants from identical twin donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704171

Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704171

Abnormal differentiation of thymocytes in mice treated with cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704171

Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704171

Erythropoietin for the treatment of porphyria cutanea tarda in a patient on long-term hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704171

Induction of graft-versus-host disease after autologous bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704171

Induced autologous graft-versus-host disease for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704171

High frequency of graft-versus-host-like syndromes following syngeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704171

7 January 2021

Acute skin GVHD following syngeneic BMT for CLL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704171

7 January 2021

Severe acute graft-versus-host disease occurring after syngeneic BMT for AML in a patient not given prior cyclosporin A therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704171

7 January 2021

Acute intestinal graft-versus-host disease in a syngeneic bone marrow transplant recipient

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704171

7 January 2021

Graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704171

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704171

1 reference

7 August 2017

1 reference